Jan 30 (Reuters) - Dr. Lal Path Labs (DLPA.NS), opens new tab reported a lower third-quarter profit on Friday after taking a one-time charge linked to India’s new labour code, despite strong demand ...
Hosted on MSN
Dr Lal PathLabs reports 16% rise in Q2 profit, declares Rs.7 interim dividend and 1:1 bonus issue
Mumbai, Oct. 31 -- Dr Lal PathLabs Limited reported consolidated revenue of Rs.731 crore for the second quarter of FY2025-26, marking a 10.7% year-on-year increase, while profit after tax (PAT) rose ...
Diagnostics services company Dr Lal Path Labs on Friday announced an interim dividend of Rs 7 per equity share for the financial year 2025-26. The company also declared a 1:1 bonus issue where it will ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results